Karl D. Murray

3.5k total citations · 1 hit paper
54 papers, 2.8k citations indexed

About

Karl D. Murray is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Developmental Neuroscience. According to data from OpenAlex, Karl D. Murray has authored 54 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 28 papers in Cellular and Molecular Neuroscience and 9 papers in Developmental Neuroscience. Recurrent topics in Karl D. Murray's work include Neuroscience and Neuropharmacology Research (19 papers), Ion channel regulation and function (10 papers) and Neurogenesis and neuroplasticity mechanisms (9 papers). Karl D. Murray is often cited by papers focused on Neuroscience and Neuropharmacology Research (19 papers), Ion channel regulation and function (10 papers) and Neurogenesis and neuroplasticity mechanisms (9 papers). Karl D. Murray collaborates with scholars based in United States, Japan and Netherlands. Karl D. Murray's co-authors include Paul J. Isackson, Edward G. Jones, Molly M. Huntsman, Christine M. Gall, Christine M. Gall, Xiao-Bo Liu, Xiaobo Liu, James S. Trimmer, Xiaobo Liu and Alessandro Graziano and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Neuron.

In The Last Decade

Karl D. Murray

47 papers receiving 2.7k citations

Hit Papers

BDNF mRNA expression is increased in adult rat forebrain ... 1991 2026 2002 2014 1991 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl D. Murray United States 27 1.8k 1.3k 772 407 252 54 2.8k
Gustavo Paratcha Argentina 30 2.0k 1.1× 1.3k 1.0× 982 1.3× 470 1.2× 274 1.1× 55 3.2k
Kazuko Sakata Japan 25 1.3k 0.7× 1.1k 0.9× 666 0.9× 323 0.8× 378 1.5× 64 2.9k
Uta B. Schambra United States 17 1.6k 0.9× 1.5k 1.2× 425 0.6× 423 1.0× 264 1.0× 20 3.4k
Henry Teng United States 8 2.1k 1.1× 929 0.7× 1.1k 1.4× 364 0.9× 347 1.4× 10 2.9k
Newton H. Woo United States 17 2.4k 1.3× 1.2k 1.0× 1.1k 1.4× 756 1.9× 327 1.3× 17 3.6k
Mathias De Roo Switzerland 22 1.3k 0.7× 748 0.6× 694 0.9× 395 1.0× 207 0.8× 30 2.3k
Rachel L. Neve United States 9 1.6k 0.8× 1.1k 0.9× 760 1.0× 231 0.6× 200 0.8× 12 2.8k
Igor Medina France 31 2.4k 1.3× 2.0k 1.5× 422 0.5× 581 1.4× 281 1.1× 59 3.5k
Christophe Pellegrino France 25 1.5k 0.8× 1.1k 0.9× 381 0.5× 374 0.9× 266 1.1× 39 2.5k
Richard H. Dyck Canada 34 1.4k 0.8× 1.1k 0.9× 457 0.6× 794 2.0× 472 1.9× 82 3.5k

Countries citing papers authored by Karl D. Murray

Since Specialization
Citations

This map shows the geographic impact of Karl D. Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl D. Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl D. Murray more than expected).

Fields of papers citing papers by Karl D. Murray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl D. Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl D. Murray. The network helps show where Karl D. Murray may publish in the future.

Co-authorship network of co-authors of Karl D. Murray

This figure shows the co-authorship network connecting the top 25 collaborators of Karl D. Murray. A scholar is included among the top collaborators of Karl D. Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl D. Murray. Karl D. Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ander, Bradley P., Kari L. Hanson, Karl D. Murray, et al.. (2025). Prenatal maternal immune activation triggers lasting cell-specific transcriptomic dysregulation in the amygdala of primate offspring. Molecular Psychiatry.
2.
Murray, Karl D., Keiko Hino, Nicholas C. Vierra, et al.. (2023). NPC1-dependent alterations in KV2.1–CaV1.2 nanodomains drive neuronal death in models of Niemann-Pick Type C disease. Nature Communications. 14(1). 4553–4553. 10 indexed citations
3.
Boktor, Joseph C., Mark D. Adame, Destanie Rose, et al.. (2022). Global metabolic profiles in a non-human primate model of maternal immune activation: implications for neurodevelopmental disorders. Molecular Psychiatry. 27(12). 4959–4973. 12 indexed citations
4.
Page, Nicholas F., Michael J. Gandal, Myka L. Estes, et al.. (2020). Alterations in Retrotransposition, Synaptic Connectivity, and Myelination Implicated by Transcriptomic Changes Following Maternal Immune Activation in Nonhuman Primates. Biological Psychiatry. 89(9). 896–910. 25 indexed citations
5.
Murray, Karl D., et al.. (2020). Age-Related Changes in Synaptic Plasticity Associated with Mossy Fiber Terminal Integration during Adult Neurogenesis. eNeuro. 7(3). ENEURO.0030–20.2020. 13 indexed citations
6.
Palacio, Stephanie, Vivien Chevaleyre, David H. Brann, et al.. (2017). Heterogeneity in Kv2 Channel Expression Shapes Action Potential Characteristics and Firing Patterns in CA1 versus CA2 Hippocampal Pyramidal Neurons. eNeuro. 4(4). ENEURO.0267–17.2017. 20 indexed citations
7.
Bishop, Hannah I., Dongxu Guan, Elke Bocksteins, et al.. (2015). Distinct Cell- and Layer-Specific Expression Patterns and Independent Regulation of Kv2 Channel Subtypes in Cortical Pyramidal Neurons. Journal of Neuroscience. 35(44). 14922–14942. 64 indexed citations
8.
Gong, Belvin, Karl D. Murray, & James S. Trimmer. (2015). Developing high-quality mouse monoclonal antibodies for neuroscience research – approaches, perspectives and opportunities. New Biotechnology. 33(5). 551–564. 26 indexed citations
9.
Berman, Robert F., Karl D. Murray, Glòria Arqué, Michael R. Hunsaker, & H. Jürgen Wenzel. (2012). Abnormal dendrite and spine morphology in primary visual cortex in the CGG knock‐in mouse model of the fragile X premutation. Epilepsia. 53(s1). 150–160. 39 indexed citations
10.
Murray, Karl D., et al.. (2011). Sema3E/Plexin-D1 Mediated Epithelial-to-Mesenchymal Transition in Ovarian Endometrioid Cancer. PLoS ONE. 6(4). e19396–e19396. 58 indexed citations
11.
Liu, Xiao-Bo, Karl D. Murray, & Edward G. Jones. (2010). Low-threshold calcium channel subunit Cav3.3 is specifically localized in GABAergic neurons of rodent thalamus and cerebral cortex. The Journal of Comparative Neurology. 519(6). 1181–1195. 31 indexed citations
12.
Graziano, Alessandro, Xiaobo Liu, Karl D. Murray, & Edward G. Jones. (2008). Vesicular glutamate transporters define two sets of glutamatergic afferents to the somatosensory thalamus and two thalamocortical projections in the mouse. The Journal of Comparative Neurology. 507(2). 1258–1276. 115 indexed citations
13.
Hayes, Shawn G., Karl D. Murray, & Edward G. Jones. (2003). Two epochs in the development of γ‐aminobutyric acidergic neurons in the ferret thalamus. The Journal of Comparative Neurology. 463(1). 45–65. 27 indexed citations
14.
Garcia, Michael L., Karl D. Murray, Virginia B. Garcia, Emanuel E. Strehler, & Paul J. Isackson. (1997). Seizure-induced alterations of plasma membrane calcium ATPase isoforms 1, 2 and 3 mRNA and protein in rat hippocampus. Molecular Brain Research. 45(2). 230–238. 31 indexed citations
15.
Murray, Karl D., et al.. (1996). A metabotropic glutamate receptor agonist regulates neurotrophin messenger RNA in rat forebrain. Neuroscience. 70(3). 617–630. 12 indexed citations
16.
Isackson, Paul J. & Karl D. Murray. (1994). Neurotrophic factors in the treatment of Alzheimer's disease. Drug News & Perspectives. 7(10). 585–592. 1 indexed citations
17.
Murray, Karl D., Christine M. Gall, Edward G. Jones, & Paul J. Isackson. (1994). Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer's disease. Neuroscience. 60(1). 37–48. 98 indexed citations
18.
Watson, Carolyn, Michael A. Watson, Karl D. Murray, Paul J. Isackson, & Elliott Richelson. (1993). Haloperidol but Not Clozapine Increases Neurotensin Receptor mRNA Levels in Rat Substantia Nigra. Journal of Neurochemistry. 61(3). 1141–1143. 36 indexed citations
19.
Gall, Christine M., Karl D. Murray, & Paul J. Isackson. (1991). Kainic acid-induced seizures stimulate increased expression of nerve growth factor mRNA in rat hippocampus. Molecular Brain Research. 9(1-2). 113–123. 248 indexed citations
20.
Isackson, Paul J., Molly M. Huntsman, Karl D. Murray, & Christine M. Gall. (1991). BDNF mRNA expression is increased in adult rat forebrain after limbic seizures: Temporal patterns of induction distinct from NGF. Neuron. 6(6). 937–948. 596 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026